Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,217,200 papers from all fields of science
Search
Sign In
Create Free Account
spinorphin
Known as:
L-Threonine, N-(N-(1-(N-(N-(N-L-leucyl-L-valyl)-L-valyl)-L-tyrosyl)-L-prolyl)-L-tryptophyl)-
, Leu-Val-Val-Tyr-Pro-Trp-Thr
, leucyl--valyl-valyl-tyrosyl-prolyl-tryptophyl-threonine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Oligopeptides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Enkephalinase inhibitors: potential agents for the management of pain.
V. Thanawala
,
V. Kadam
,
R. Ghosh
Current Drug Targets
2008
Corpus ID: 35095992
Management of acute and chronic pain has always been a key area of clinical research. Enkephalinase inhibitors (EIs) seem to be…
Expand
2007
2007
Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.
K. Jung
,
H. Moon
,
G. Lee
,
Hyun-Ho Lim
,
Chul-Seung Park
,
Yong‐Chul Kim
Journal of Medicinal Chemistry
2007
Corpus ID: 46007715
Spinorphin, an endogenous antinociceptive peptide (LVVYPWT), showed potent and non-competitive antagonism at the ATP-activated…
Expand
Review
2002
Review
2002
Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation.
Y. Yamamoto
,
H. Ono
,
A. Ueda
,
M. Shimamura
,
K. Nishimura
,
T. Hazato
Current protein and peptide science
2002
Corpus ID: 20716085
It is possible that enkephalins are involved in the pain-modulating mechanism in the spinal cord. Enkephalins, however, are short…
Expand
2001
2001
The Endogenous Opioid Spinorphin Blocks fMet-Leu-Phe-Induced Neutrophil Chemotaxis by Acting as a Specific Antagonist at the N-Formylpeptide Receptor Subtype FPR
T. Liang
,
Ji-Liang Gao
,
Omid Fatemi
,
M. Lavigne
,
T. Leto
,
P. Murphy
Journal of Immunology
2001
Corpus ID: 12626330
Spinorphin is an endogenous heptapeptide (leucylvalylvalyltyrosylprolyltryptophylthreonine), first isolated from bovine spinal…
Expand
2001
2001
Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice.
M. Honda
,
H. Okutsu
,
+4 authors
H. Ono
Japanese Journal of Pharmacology
2001
Corpus ID: 46182810
Spinorphin (LVVYPWT) has been isolated from the bovine spinal cord as an endogenous inhibitor of enkephalin-degrading enzymes. It…
Expand
2000
2000
Characterization of tynorphin, a potent endogenous inhibitor of dipeptidyl peptidaseIII
Yukio Yamamoto
,
J. Hashimoto
,
M. Shimamura
,
Teruhide Yamaguchi
,
T. Hazato
Peptides
2000
Corpus ID: 30916029
2000
2000
Identification of dipeptidyl peptidase III in human neutrophils.
Jun-ichi Hashimoto
,
Yukio Yamamoto
,
Hisasi Kurosawa
,
Kinya Nishimura
,
Tadahiko Hazato
Biochemical and Biophysical Research…
2000
Corpus ID: 36276506
We have found activity of dipeptidyl peptidase (DPP) III, one of the most important enkephalin-degrading enzymes in the central…
Expand
1997
1997
Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of…
Q. Zhao
,
J. Piot
Neuropeptides
1997
Corpus ID: 25605324
Highly Cited
1993
Highly Cited
1993
Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord.
Kinya Nishimura
,
T. Hazato
Biochemical and Biophysical Research…
1993
Corpus ID: 22686933
We isolated a potent inhibitor of enkephalin-degrading enzymes from bovine spinal cord and determined its amino-acid sequence and…
Expand
1993
1993
[Study of a new endogenous inhibitor of enkephalin-degrading enzymes; pharmacological function and metabolism of spinorphin].
K. Nishimura
,
M. Ueki
,
H. Kaneto
,
T. Hazato
Masui. The Japanese journal of anesthesiology
1993
Corpus ID: 40620649
Spinorphin, a potent inhibitor of enkephalin degrading enzyme isolated from the bovine spinal cord, produces a dose-related…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE